P2Y13 shows anti-adipogenic effects (170). Mice P2Y13 KO improve outcome in metabolic syndrome with an increased protection against developing an insulin resistance as shown through an improved glucose tolerance and basal glucose levels, a decelerated weight gain and a better metabolic turnover (183). Here, P2RY13 is linked to metabolic syndrome.